Cytomegalovirus (CMV) is the leading transmittable cause of congenital brain abnormalities in children and infection results in fatal ventriculoencephalitis in advanced acquired immunodeficiency syndrome (AIDS) patients. Pathology associated with CMV brain infection is seen predominantly in the periventricular region, an area known to harbor neural stem cells (NSCs). In the present study, using an adult model of murine CMV brain infection, the authors demonstrated that nestin-positive NSCs in the subventricular zone are susceptible to murine CMV infection. Furthermore, primary NSC cultures supported productive murine CMV replication with a 1000-fold increase in viral titers by 5 days post infection (d.p.i). Previous studies from the authors' laboratory demonstrated that CD8 lymphocytes were essential in protecting the brain against murine CMV infection. In the present study, the authors found that interferon (IFN)-g treatment increased the expression of major histocompatibility complex (MHC) class I on NSCs. Viral infection, on the other hand, inhibited this IFN-g Á induced MHC up-regulation. In addition to increasing MHC class I expression, IFN-g (but not tumor necrosis factor [TNF]-a, interleukin [IL]-1b, or IL-10) also suppressed NSC proliferation in vitro. This decrease in proliferation was not accompanied by apoptosis or extracellular release of cellular lactate dehydrogenase (LDH), suggesting that the effects were not due to direct cytotoxicity. These studies demonstrate that NSCs are susceptible to murine CMV infection and inflammatory mediators, such as IFN-g, alter cellular characteristics which may have an impact on their reparative functions.
Introduction
Cytomegalovirus (CMV) brain disease is predominantly seen during congenital infection in the developing fetus or as a fatal ventriculoencephalitis in the severely immunocompromised adult with advanced human immunodeficiency virus type 1 (HIV-1) disease. In both congenitally infected children and adult brain infections, CMV preferentially infects cells in the ventricular or subventricular regions (Grassi et al, 1998; Perlman and Argyle, 1992; Schmidbauer et al, 1989) . This periventricular predilection has also been recapitulated in mouse models of congenital CMV (Li and Tsutsui, 2000) . The subventricular region of the brain is known to harbor neural stem cells (NSCs), a population of undifferentiated cells that have been retained in the adult brain from fetal development which have the ability to migrate, proliferate, and differentiate into neurons, astrocytes, and oligodendrocytes. These cells potentially repopulate damaged brain tissue and aid in the establishment of new neuronal circuits during memory formation in the adult (Gage, 2000; Ni et al, 2004; Temple, 2001) .
The neuropathological outcomes associated with CMV brain infection may result from damage or functional modulation of NSCs. Congenital CMV infection is the major cause for birth defects and childhood disorders in the United States. Approximately 8000 children are affected each year with some neurological sequelae related to congenital CMV infection. This statistic surpasses many of the better known childhood disorders, like Down syndrome, fetal alcohol syndrome, or spinal bifida (Cannon and Davis, 2005) . However, little is known about the neuropathogenesis of CMV brain infection. Our laboratory and others have shown that human neural precursor cells are susceptible to CMV infection (Cheeran et al, 2005b; McCarthy et al, 2000; Odeberg et al, 2006) . CMV infection has also been shown to alter the cellular differentiation profiles of neural precursor cells (Odeberg et al, 2006 (Odeberg et al, , 2007 . In experimental murine CMV infections, it has been shown that intermediate-early (IE) gene expression is retained in the cortex of the postnatal brain infected in utero, presumably resulting from the maturation of infected neural stem cells into neurons (Ishiwata et al, 2006) . Similar expression of IE in neurons of the cerebellum is associated with delayed maturation and migration of precursors cells (Koontz et al, 2008) . A more lucid understanding of the interaction between CMV and NSCs is essential to delineate the neuropathogenic mechanisms of viral infection.
Previously, we have shown that murine CMV brain infection induces a transient increase in proinflammatory cytokine production and leukocyte accumulation that is protective in immunocompetent adult mice . The neuroinflammatory response involves expression of chemokines, consequent trafficking of peripheral immune cells into the brain, subsequent regulation of these responses by anti-inflammatory cytokines, and ultimately resolution of infection. When these inflammatory processes are interrupted, either in immunodeficient animals or in interleukin (IL)-10Á deficient animals, murine CMV brain infection turns lethal (Cheeran et al, 2005a; Cheeran et al, 2007) . Successful defense against murine CMV brain infection requires CD8(') T lymphocytes, via a perforin-mediated mechanism to clear infection. Meanwhile, cells of the central nervous system (CNS) are known to express relatively low major histocompatibility complex (MHC) class I levels. Viral infection and consequent interferon (IFN)-g expression increase MHC expression on neurons and glia (Rodriguez et al, 2003) , potentially influencing pathogen clearance from the CNS. In the present study, we investigated the role of murine CMV infection and neuroinflammatory mediators in altering MHC class I expression on NSC. Additional studies were performed to investigate the role of inflammatory cytokines on NSC self-renewal responses, essential to maintain germinal areas of the brain.
Results

Infection of neural stem cells in vivo
Previous studies performed in our laboratory have shown that subsequent to an intracerebroventricular (i.c.v.) infection with murine CMV, viral expression was restricted to the periventricular region in immunocompetent animals and spread into the parenchyma only in the absence of an effective CD8 response (Cheeran et al, , 2005a . To determine if infected cells around the ventricles were NSCs, we assayed adjacent coronal brain sections from murine CMV-infected severely compromised immunodeficient (SCID) mice for immunoreactivity to b-galactosidase expression (reporter gene expressed by the virus) and nestin (a stem cell marker) at 5 days post infection (d.p.i.). As expected, viral gene expression was detected predominantly around the ventricles. The adjacent tissue sections showed overlapping regions of immunoreactivity to nestin (Figure 1) . Furthermore, double immunostaining of brain sections for b-galactosidase and nestin showed dual immunoreactivity, confirming that the stem cells were susceptible to CMV infection in vivo ( Figure 1F ).
In vitro infection of NSCs
Murine CMV infection of stem cells was further characterized using NSC cultures derived from mouse embryonic brains (embryonic day 14.5 [E14.5]). To ensure purity of the culture system and multipotency of cells in vitro, NSCs were analyzed for nestin expression and assayed for their ability to differentiate into astrocytes, neurons, and oligodendrocytes. When grown under serum-free conditions, in selective stem cell growth media containing epidermal (epidermal growth factor (EGF)) and fibroblast growth factor (FGF), !90% of the cultured cells were positive for nestin expression (Figure 2A and B) . When NSCs were induced to differentiate using medium containing serum, these cells differentiated into astrocytes (expressing glial fibrillary acidic protein [GFAP] ), neurons (expressing class III b-tubulin), and oligodendrocytes (immunoreactive for O4) within 7 days ( Figure 2C to E).
The majority of the cells in differentiated cultures were of an astrocyte phenotype, with approximately 5% of the cells expressing neuronal or oligodendrocyte markers. The undifferentiated NSC cultures supported productive viral replication. One-step growth kinetics of murine CMV in NSC cultures showed a 2 to 3 log increases in viral titer, with peak viral growth at 5 d.p.i. (Figure 2F ). Expression of viral glycoprotein, gB commenced at 48 h p.i. and continued to increase over time ( Figure 2G ).
Interferon-g stimulates MHC class I expression on NSCs To determine if NSCs could potentially serve as targets for CD8 T-cell recognition, MHC class I expression was evaluated on both infected and uninfected cells. Relatively low levels of expression were detected on culture-derived NSCs by flow cytometry. MHC-I expression was detected in 18.5%93.7% of untreated NSCs (Figure 3 ) derived from multiple mouse embryos (ranging from 8% to 30%) with mean fluorescence intensity (MFI) of 258980 (versus isotype controls 052.8912.1). We next asked if inflammatory mediators, such as interferon (INF)-g, tumor necrosis factor (TNF)-a, interleukin (IL)-10, and IL-6, that are expressed during murine CMV brain infection Cheeran et al, 2007) , alter MHC-I expression. Within 24 h of treatment with IFN-g (25 to 100 pg/ ml; 2 to 8 IU/ml), mean fluorescence intensity (MFI) for MHC class I expression increased about 18-fold to 49419414 and was expressed on 88% to 95% of the NSCs ( Figure 3A and B). At 40 h post treatment, MFI of class I expression further increased, reaching 88339250 (a 30-fold increase over untreated cells). The effect of IFN-g on NSCs was also dose responsive, inducing saturating levels ( !99%; MFI ! 9500) class I expression at 62 pg/ml ( Figure 3A ). In addition, 24 h post treatment with TNF-a the proportion of NSCs expressing MHC class I increased from 18.5%93.7% in untreated cultures to 37.9%95.4% with cytokine treatment (P 0.016; Figure 3C ). No further increase in class I expression was observed at 48 h. Finally, IL-6 and IL-10 had no effect on MHC class I expression on NSCs.
Viral infection inhibits MHC class I expression on NSCs
We next determined if murine CMV infection would inhibit class I expression on NSCs. Using a recombinant murine CMV expressing a green flurescent protein (GFP) reporter (Reuter et al, 2004) to identify infected cells, MHC class I expression was analyzed on infected NSCs. MHC expression remained unaltered in GFP-expressing infected cells at 24 h p.i. However, an increase (approximately twofold) in MHC expression was seen in the uninfected fraction of cultured NSCs ( Figure 3D and E). Both . Following in vitro differentiation in medium containing 2% FBS for 7 days, cells were stained with (C) anti-GFAP antibody (red), an astrocyte marker, contrasted with DAPI nuclear staining (blue); (D) anti-Tuj-1 antibody (green), an early neuronal cell marker, contrasted with DAPI nuclear staining (blue); and (E) anti-O4 antibody (red), an oligodendrocyte marker, contrasted with DAPI nuclear staining (blue). (F) One-step growth curve for murine CMV (Smith strain) in NSC monolayer cultures measured by 50% tissue culture infectious dose (TCID 50 ) assay. NSCs were infected with murine CMV (MOI01), freeze-thaw cell lysates of infected cultures were harvested at the indicated time points and viral titers were determined by TCID 50 assay on NIH 3T3 cells. Viral titers at day 0 represent MCMV detected after 2 h of adsorption and subsequent washing. Data are presented as mean (9 SEM) titers pooled from three independent experiments using cells isolated from different brain tissue specimens. (G) Quantitative real-time PCR demonstrating the kinetics of murine CMV glycoprotein B (gB) expression in infected NSCs.
by a TCID 50 assay on NIH 3T3 cells) was not affected by IFN-g treatment at various doses between 3 and 80 pg/ml (0.3 (6 IU/ml).
IFN-g treatment inhibits NSC proliferation
To determine if IFN-g treatment altered NSC proliferation, varying doses of IFN-g were added to undifferentiated cultures for 4 days and the cells were assessed for proliferative activity by measuring live cell density using an MTT uptake assay. IFN-g treatment, using as little as 20 IU (250 pg/ml), suppressed NSC proliferation by 90% compared to untreated cultures (P B.01). This inhibitory response was dose-responsive in that 2 IU (25 pg/ml) of IFN-g suppressed proliferation to 30% of untreated cells (P 0.014) and 2.5 pg/ml (0.2 IU) had no effect (Figure 4 A). Treatment with other pro-and anti-inflammatory cytokines, such as IL-1b, TNF-a, and IL-10, had no significant effect on NSC proliferation ( Figure 4B ). To further confirm that this inhibition of cell proliferation was not due to toxicity and cell death, we tested the supernatants obtained from cytokine-treated NSC cultures for lactate dehydrogenase (LDH) release, indicative of cell death and loss of membrane integrity. No significant increase in LDH release was detected with any of the cytokines used in this study.
3 Hthymidine uptake, a direct measure of NSC proliferation, was also significantly decreased with IFN-g treatment at 20 pg/ml, 0.2 ng/ml, and 2 ng/ml (P B .001; Figure 4C ). Furthermore, this decrease in cell proliferation was evident as early as 24 h post IFN-g treatment ( Figure 4D ). Furthermore, analysis of DNA fragmentation by Hoechst staining revealed no increase in apoptotic nuclei in IFN-gÁtreated NSC cultures at doses B250 pg/ml (20 IU; data not shown).
Discussion
In the present study, we demonstrate that murine CMV replicates in neural stem cells both in vivo and in vitro. Previous studies using human neural precursor cells showed similar 1000-fold increases in human CMV replication, with detectable immediate-early gene expression at 8 h p.i. (Cheeran et al, 2005b) . Other published studies have shown that immature neural cells in the subventricular zone of the developing mouse brain are susceptible to CMV infection (Li and Tsutsui, 2000) , and their numbers are closely associated with susceptibility of the brain to CMV infection. CMV brain infection is associated with a transient but robust inflammatory response that includes the expression of soluble mediators and drives the infiltration of systemic immune cells. Using an adult murine model of CMV brain infection, we have demonstrated that systemic T lymphocytes, which infiltrate the brain, are responsible for the protection of immunodeficient animals against CMV infection, via a perforin-dependent CD8' T-lymphocyte response (Cheeran et al, , 2005a . A similar study reported that murine CMV (MCMV)-specific immune cells, particularly CD4' T cells, rapidly cross the blood-brain barrier, congregate at sites of specific MCMV infection, and eliminate acute MCMV within the brain (Reuter et al, 2005) . These studies suggest that infiltrating T cells clear viral brain infection, potentially through an MHC-dependent, perforinmediated cytotoxic T-lymphocyte (CTL) response.
In the present study, we demonstrated that very low levels of MHC class I molecules are normally expressed on neural stem cells. Lack of MHC expression, in conjunction with the immunosuppressive CNS microenvironment afforded by antiinflammatory cytokines such as transforming growth factor (TGF)-b (Mammolenti et al, 2004; Ubiali et al, 2007) , may allow this critical cell population to remain unrecognized by the immune system. Lack of MHC expression not only prevents NSC recognition by CTLs, but also inhibits natural killer cell activity, keeping these cells immunologically protected in the noninflamed brain (Hori et al, 2003; Mammolenti et al, 2004) . Infection of the brain results in a robust neuroinflammatory response, which includes expression of TNF-a, IFN-g, and IL-10 (Cheeran et al, , 2007 . Here, we have shown that treatment with both TNF-a and IFN-g increases MHC I expression on neural stem cells, a finding that indicates that the neuroinflammatory microenvironment induced by infection may abrogate the immune privilege afforded to these cells.
MHC class I expression on NSCs increased robustly following IFN-g treatment, attaining levels of up to 30-fold greater than untreated cells. Similar studies by Mammolenti et al have shown that IFN-g up-regulates class I expression on neural stem cells without altering their multipotent ability to differentiate into various cell types (Mammolenti et al, 2004) . In the present study, we show that saturating levels of MHC-I expression are attained at relatively low concentrations (62 pg/ml) of IFN-g, 2.5 to 5 IU / ml (R&D Systems). Treatment with IFN-g has been demonstrated to make neural stem cells susceptible to CTL activity (Mammolenti et al, 2004) , potentially rendering the infected germinal centers of the brain susceptible to depletion by the systemic immune response.
Several viral genes that target MHC class I expression pathways are carried by both murine and human CMVs, which are well known for their ability to evade the immune system in an infected host. In the present study, we demonstrate that CMV infection inhibits MHC I expression in the uninfected and IFN-gÁtreated NSCs. The inhibition of MHC expression was seen in the infected cell population without affecting expression in the bystander/uninfected population. Murine CMV expresses three viral genes (m4, m6, and m152) that inhibit MHC-I expression by either inhibiting the complex from reaching the surface or by associating with the complex at the cell surface (Hengel et al, 1999) . Through inhibition of MHC expression, the virus has developed distinct advantages which allow better establishment of infection and latency as well as more efficient transmission (Doom and Hill, 2008) . In the developing CNS, inhibition of MHC may have an effect on development of neural circuits, because recent studies have demonstrated novel roles for MHC class I that involve neuronal differentiation, plasticity, establishment of synapses, and modulating synaptic strength (Boulanger, 2004; Goddard et al, 2007; Huh et al, 2000) . Viral inhibition of MHC class I expression may thus have a wide-ranging impact on CMV neuropathogenesis.
Interactions between the immune system and neural stem cells are critical not only in brain development, but also in reparative processes during injury. We found that IFN-g inhibits NSC proliferation in a dose-dependent manner. This decrease in proliferation was measured both in terms of the total density of live cells post treatmtent with IFN-g and by 3 H-thymidine uptake by cells. Decreased NSC proliferation was neither associated with a concomitant increase in LDH release from the cells, indicative of cell necrosis, nor apoptosis, indicating that IFN alters NSC proliferation without inducing cytotoxicity. In addition to the lack of cytotoxicity in neurosphere cultures, IFN-g also has the propensity to induce neurogenesis and inhibit the differentiation of NSCs into astrocytes (RicciVitiani et al, 2006; Wong et al, 2004) . Inflammationassociated neurogenesis and oligodendrogenesis have also been found to be blocked by endotoxinactivated microglia, but were induced by microglia activated in response to T cellÁproduced cytokines (IL-4 and low-level IFN-g; Butovsky et al, 2006) .
In our study, TNF-a was not cytotoxic, nor did it have any effect on NSC proliferation. Similar studies using human neural progenitor cells have demonstrated that TNF-a treatment induced apoptosis through the TNF receptor, TNFRI (Sheng et al, 2005) . TNF-a was also shown to be cytotoxic to murine neurosphere cultures (Wong et al, 2004) . This discrepancy in findings may reflect the differences in species, stage of cellular differentiation or the culture system used in the assay. Additionally, in vivo experiments have shown that inflammationinduced proliferation in the subventricular zone was greater in animals that lacked a functional TNFR1, suggesting that TNF may indeed be a negative regulator of NSC proliferation in mouse brains (Iosif et al, 2006) . Thus, although in vitro studies provide great insights into the effect of specific cytokines on NSCs, their effects in vivo are influenced by numerous additional factors, including bystander cell responses, soluble factors in the inflammatory milieu, and the antigen-specific response of systemic immune cells.
Materials and methods
Viruses RM461, a recombinant murine CMV expressing Esherichia coli b-galactosidase under the control of the human ie1/ie2 promoter/enhancer (Stoddart et al, 1994) , was provided by Edward Mocarski. Viral stocks were passaged in murine salivary glands to retain their virulence. Virus isolated from the salivary glands was then passaged once on NIH3T3 fibroblasts, followed by purification over a sucrose gradient. Sucrose gradient-purified RM461 was used for intracerebroventricular (i.c.v.) infections. A recombinant murine CMV expressing green fluorescent protein (GFP) under control of the human elongation factor-1a promoter inserted at the immediate-early gene (IE2) site (strain K181 MC.55 [ie2 -GFP ' ]) was provided by Jon Reuter (Reuter et al, 2004; van Den Pol et al, 1999) . The GFPexpressing virus was expanded on NIH 3T3 mouse fibroblasts and purified by centrifugation over a sucrose cushion.
Intracerebroventricular infection CMV infection of mice was performed via an i.c.v. route as described previously . Briefly, female wild-type BALB/c (8 to 10 weeks) were anesthetized using a combination of ketamine and xylazine (100 mg and 10 mg/kg body weight, respectively) and immobilized on a small animal stereotactic instrument equipped with a Cunningham mouse adapter (Stoelting, Wood Dale, IL). The skin and underlying connective tissue were reflected to expose reference sutures (sagittal and coronal) on the skull. The sagittal plane was adjusted such that the bregma and lambda were positioned at the same coordinates on the vertical plane. Salivary gland passaged murine CMV RM461 (1.5 )10 5 TCID 50 ), was injected slowly into the right lateral ventricle at 0.9 mm lateral, 0.5 mm caudal to the bregma and 3.0 mm ventral to the skull surface using a Hamilton syringe fitted to a 28-G cannula. The injection was delivered over a period of 3 to 5 min. The opening in the skull was sealed with bone wax and the skin closed using 9-mm wound clips (Stoelting).
Immunohistochemistry
Immunofluorescent staining was performed using the protocol previously described (Lokensgard et al, 1999) . Briefly, brains were harvested from infected mice that were sacrificed and perfused with serial washes of 2% sodium nitrate and phosphate-buffered saline (PBS) to remove contaminating blood cells and prefixed with 4% paraformaldehyde. Murine brains were subsequently submerged in 4% paraformaldehyde for 24 h and transferred to 30% sucrose solution for 2 days. Brain tissue slices (30-mm) were stained with a monoclonal antibody to b-galactosidase (Sigma, St. Louis, MO) or nestin (10 mg/ml; Chemicon, Temecula, CA), followed by a biotin-labeled donkey anti-mouse immunoglobulin G (IgG) antibody (Jackson Immunoresearch, West Grove, PA) and a fluorescein-streptavidin conjugate (Vector Laboratory, Burlingame, CA). Dual immunofluorescent staining for b-galactosidase and nestin was performed as described above and was counter stained with 4?,6-diamidino-2-phenyindole (DAPI), a nucleic acid dye (Chemicon).
Murine NSC culture Murine NSCs were cultured from the brains of embryonic day 14.5 (E14.5) fetal mice, using conditions described by Kim and Morshead (2003) and our previous studies (Ni et al 2004) with few modifications. Briefly, timed-pregnant mouse embryos (E14.5) were dissected in Hank's buffer (Sigma). Embryos were measured and examined for morphological hallmarks characteristic of the correct gestational time. After decapitation and removal of skin, skull, and meninges, cerebral cortices were collected and mechanically triturated in Hank's buffer. Dissociated cells were collected and resuspended in serum-free medium containing: Dulbecco's modified Eagle's medium (DMEM)/F12, 8 mM glucose, glutamine, 20 mM sodium bicarbonate, and N2 Plus supplement (R&D Systems, Minneapolis, MN). Dissociated cells (2)10 5 ) were then plated on 10-cm diameter dishes, precoated with 15 mg/ml poly-l-ornithine and 1 mg/ml bovine fibronectin (R&D Systems) and cultured in N2 medium supplemented with basic fibroblast growth factor (bFGF) (20 ng/ml) and epidermal (epidermal growth factor (EGF)) (20 ng/ml; R&D Systems). Cultures were maintained at 378C in a 5% CO 2 incubator and monolayers were subcultured at 60% to 70% confluence in N2 Plus medium with bFGF and EGF. NSCs were induced to differentiate by addition of 2% FBS (Hyclone) and the withdrawal of bFGF and EGF.
Immunostaining of NSCs
Undifferentiated and differentiated NSC cultures were fixed with 4% paraformaldehyde and stained for nestin (NSC), Tuj1 (a neuronal marker), glial fibrillary acidic protein (GFAP) (astrocytes), and O4 (oligodendrocytes). Anti-nestin, anti-Tuj1, and anti-O4 (R&D Systems) antibodies were used at 10 mg/ml concentrations and anti-GFAP antibody (Dako, Carpentaria, CA) was used at 1:200. Cells were fixed with 4% paraformaldehyde and 0.15% picric acid in PBS at room temperature for 20 min and were then permeated and blocked with 0.1% triton X-100, 1% bovine serum albumin (BSA), and 10% normal donkey serum in PBS at room temperature for 45 min. After blocking, cells were incubated with diluted primary antibody overnight at 48C and sequentially with fluorescence-coupled anti-mouse IgG antibody (Jackson Laboratory, Bar Harbor, ME) at room temperature in the dark for 1 h. Cells were washed between each step with 0.1% BSA in PBS.
Real-time PCR
Total RNA and DNA were extracted from brain tissue homogenates using the Trizol Reagent (Invitrogen, Carlsbad, CA). cDNA was synthesized using 1 mg of total RNA, SuperScript II reverse transcriptase (Invitrogen Life Technologies, Carlsbad, CA) and oligo dT 6-12 primers (Sigma-Genosys, The Woodlands, TX). Quantitative real-time polymerase chain reaction (PCR) was performed using the FullVelocity SYBR Green QPCR master mix (Stratagene, La Jolla, CA) following the manufacturer's specifications. The 25-ml final reaction volume consisted of premade reaction mix (SYBR Green I dye, reaction buffer, Taq DNA polymerase, and dNTPs), 0.3 mM of each primer, and 0.5 ng cDNA in water. Reaction conditions for PCR for the Mx3000P QPCR System (Stratagene) were as follows: polymerase activation at 958C for 5 min, 40 denaturation cycles of 958C for 10 s, annealing at 608C for 10 s, and elongation at 728C for 10 s. Primers for murine CMV were designed from the gene encoding glycoprotein B (gB; GenBank accession no. M86302, 5?-CGCT GGTCGTCTTTCAGTTC-3? and 5?-CTGTTCGTG TCGCAGTTCTC-3?, 112-bp product). Primers recognizing the housekeeping gene b-actin were designed from the mouse b-actin DNA sequence (GenBank accession no. NM_007393, 5?-GGGCTATGCTCT CCCTCAC-3? and 5?-GATGTCACGCACGATTTCC-3?, 100-bp product). A melting curve analysis was performed to assess primer specificity and product quality by denaturation at 958C, annealing at 658C, and melting at a rate of 0.18C/s to 958C. The relative levels of gB expression were quantified using the 2((Delta Delta C T ) (Livak and Schmittgen, 2001) .
Flow-cytometry analysis of NSCs
NSCs were stained for nestin expression by fixing cells in 4% paraformaldehyde (in PBS) for 20 min and incubating in SAP buffer (2% fetal calf serum [FCS] , 0.5% saponin, and 0.1% sodium azide in PBS) containing anti-rat nestin-phycoerythrin (PE) monoclonal antibody or IgG-PE isotype antibody (R&D Systems). Following incubation for 30 min at room temperature, the cells were washed once with SAP buffer, once with PBS, resuspended in 400 ml of PBS, and analyzed on a FACScan flow cytometer (Becton-Dickinson, Mountain View, CA). Five thousand events were collected and analyzed using CELL Quest software. To study the dynamics of MHC class I expression on NSCs, monolayer cultures were dissociated into single-cell suspension by incubating in Ca 2' /Mg 2' -free Hanks balanced salt solution (without trypsin) and preincubated with anti-CD32/CD16 monoclonal antibody (2.4G2) to inhibit nonspecific binding. Both infected and uninfected cells were then stained with an anti-H-2D b specific, PE-conjugated monoclonal antibody (BioLegend, San Diego, CA). Data were collected on a BD FACSCanto flow cytometer (Becton-Dickinson, CA) and analyzed using FlowJo (Tree Star, CA).
MTT assay: Analysis of live cell density in NSC cultures MTT assay is a means of measuring the activity of living cells via mitochondrial dehydrogenase activity. After designated treatment time periods, MTT ([3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide]; final concentration of 1 mg/ml) was added to NSC cultures for 4 h followed by addition of lysis buffer (20% sodium dodecyl sulfate [SDS] [w/v] in 50% N, N-dimethyl formamide, pH 4.7, adjusted with 2.5% acetic acid and 1 N HCl [32:1]) for 16 h. Cell lysates were collected and absorbance will be read at 600 nm (Molecular Devices, Sunnyvale, CA) to reflect uptake of MTT by live cells.
LDH assay: Analysis of cytotoxicity in cytokinetreated cultures Cytotoxicity of cytokine treatment was assayed using the CytTox96 cell death assay (Promega), which measures the extracellular release of lactate dehydrogenase (LDH) into the medium by dead cells, according to the manufacturer's instructions. Data obtained as absorbance values of treated cells were expressed as a percentage of untreated cells (9 SD) after correcting for background from media without cells.
added to the culture (1 mCi per well) and incubated overnight before being harvested and measured for 3 H-thymidine incorporation using a beta-counter.
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